Role of caspases, calpain and cdk5 in ammonia-induced cell death in developing brain cells

Neurobiology of Disease

Volumn 32, Issue 2, 2008, Pages 281-292

  Cagnon, Laurène ^a   Braissant, Olivier ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Ammonia; Calpain; Caspase; cdk5; Neuroprotection; Roscovitine

Indexed keywords

AMMONIA; CALPAIN; CASPASE; CASPASE 2; CASPASE 3; CASPASE 8; CASPASE 9; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE 5 ACTIVATOR P25; CYCLIN DEPENDENT KINASE 5 ACTIVATOR P35; ENZYME ACTIVATOR; INTERLEUKIN 1BETA CONVERTING ENZYME; NEUROFILAMENT M PROTEIN; ROSCOVITINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; CELL AGGREGATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EXPERIMENTAL MODEL; FETUS; HYPERAMMONEMIA; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVE FIBER GROWTH; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RAT; TELENCEPHALON;

AMMONIA; ANIMALS; CALPAIN; CASPASES; CELL DEATH; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 5; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; ENZYME INHIBITORS; IMMUNOPRECIPITATION; L-LACTATE DEHYDROGENASE; MOLECULAR WEIGHT; NERVE TISSUE PROTEINS; NEURONS; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 53749090841     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.07.012     Document Type: Article

References (62)

1. Bach S., Knockaert M., Reinhardt J., Lozach O., Schmitt S., Baratte B., Koken M., Coburn P., Tang L., Jiang T., Liang D., Galons H., Dierick J.F., Pinna L.A., Meggio F., Totzke F., Schächtele C., Lerman A.S., Carnero A., Wan Y., Gray N., and Meijer L. Roscovitine targets, protein kinases and pyridoxal kinase. J. Biol. Chem. 280 (2005) 31208-31219
2. Blomgren K., Zhu C., Wang X., Karlsson J.O., Leverin A.L., Bahr B.A., Mallard C., and Hagberg H. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"?. J. Biol. Chem. 276 (2001) 10191-10198
3. Blomgren K., Leist M., and Groc L. Pathological apoptosis in the developing brain. Apoptosis 12 (2007) 993-1010
4. Braissant O., Honegger P., Loup M., Iwase K., Takiguchi M., and Bachmann C. Hyperammonemia: regulation of argininosuccinate synthetase and argininosuccinate lyase genes in aggregating cell cultures of fetal rat brain. Neurosci. Lett. 266 (1999) 89-92
5. Braissant O., Henry H., Villard A.M., Zurich M.G., Loup M., Eilers B., Parlascino G., Matter E., Boulat O., Honegger P., and Bachmann C. Ammonium-induced impairment of axonal growth is prevented through glial creatine. J. Neurosci. 22 (2002) 9810-9820
6. Braissant O., Cagnon L., Monnet-Tschudi F., Speer O., Wallimann T., Honegger P., and Henry H. Ammonium alters creatine transport and synthesis in a 3D-culture of developing brain cells, resulting in secondary cerebral creatine deficiency. Eur. J. Neurosci. 27 (2008) 1673-1685
7. Cagnon L., and Braissant O. Hyperammonemia-induced toxicity for the developing central nervous system. Brain Res. Rev. 56 (2007) 183-197
8. Cheung Z.H., and Ip N.Y. Cdk5: mediator of neuronal death and survival. Neurosci. Lett. 361 (2004) 47-51
9. Enns G.M., Berry S.A., Berry G.T., Rhead W.J., Brusilow S.W., and Hamosh A. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N. Engl. J. Med. 356 (2007) 2282-2292
10. Felipo V., Grau E., Minana M.D., and Grisolia S. Ammonium injection induces an N-methyl-D-aspartate receptor-mediated proteolysis of the microtubule-associated protein MAP-2. J. Neurochem. 60 (1993) 1626-1630
11. Gropman A.L., Summar M., and Leonard J.V. Neurological implications of urea cycle disorders. J. Inherit. Metab. Dis. 30 (2007) 865-879
12. Hahn C.M., Kleinholz H., Koester M.P., Grieser S., Thelen K., and Pollerberg G.E. Role of cyclin-dependent kinase 5 and its activator P35 in local axon and growth cone stabilization. Neuroscience 134 (2005) 449-465
13. Hallows J.L., Chen K., DePinho R.A., and Vincent I. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice. J. Neurosci. 23 (2003) 10633-10644
14. Harada T., Morooka T., Ogawa S., and Nishida E. ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat. Cell Biol. 3 (2001) 453-459
15. Harding B.N., Leonard J.V., and Erdohazi M. Ornithine carbamoyl transferase deficiency: a neuropathological study. Eur. J. Pediatr. 141 (1984) 215-220
16. Herrup K., and Yang Y. Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?. Nat. Rev. Neurosci. 8 (2007) 368-378
17. Hillmann P., Kose M., Sohl K., and Muller C.E. Ammonium-induced calcium mobilization in 1321N1 astrocytoma cells. Toxicol. Appl. Pharmacol. 227 (2007) 36-47
18. Honegger P., and Schilter B. Serum-free aggregate cultures of fetal rat brain and liver cells: methodology and some practical applications in neurotoxicology. In: Zbinden G. (Ed). The Brain in Bits and Pieces. In Vitro Techniques in Neurobiology, Neuropharmacology and Neurotoxicology (1992), MTC Verlag, Zollikon, Switzerland 51-79
19. Honegger P., and Monnet-Tschudi F. Aggregating neural cell culture. In: Fedoroff S., and Richardson E. (Eds). Protocols for Neural Cell Culture (2001), Humana Press Inc., Totowa, NJ 199-218
20. Huang R., Kala G., Murthy R.K., and Hertz L. Effects of chronic exposure to ammonia on glutamate and glutamine interconversion and compartmentation in homogeneous primary cultures of mouse astrocytes. Neurochem. Res. 19 (1994) 257-265
21. Jamsa A., Backstrom A., Gustafsson E., Dehvari N., Hiller G., Cowburn R.F., and Vasange M. Glutamate treatment and p25 transfection increase Cdk5 mediated tau phosphorylation in SH-SY5Y cells. Biochem. Biophys. Res. Commun. 345 (2006) 324-331
22. Kesavapany S., Li B.S., and Pant H.C. Cyclin-dependent kinase 5 in neurofilament function and regulation. Neurosignals 12 (2003) 252-264
23. Klejman A., Wegrzynowicz M., Szatmari E.M., Mioduszewska B., Hetman M., and Albrecht J. Mechanisms of ammonia-induced cell death in rat cortical neurons: roles of NMDA receptors and glutathione. Neurochem. Int. 47 (2005) 51-57
24. Kosenko E., Kaminsky Y., Solomadin I., Marov N., Venediktova N., Felipo V., and Montoliu C. Acute ammonia neurotoxicity in vivo involves increase in cytoplasmic protein P53 without alterations in other markers of apoptosis. J. Neurosci. Res. 85 (2007) 2491-2499
25. Kroemer G., and Martin S.J. Caspase-independent cell death. Nat. Med. 11 (2005) 725-730
26. Kuida K., Zheng T.S., Na S., Kuan C., Yang D., Karasuyama H., Rakic P., and Flavell R.A. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384 (1996) 368-372
27. Kurihara T., and Tsukada Y. The regional and subcellular distribution of 2′,3′-cyclic nucleotide 3′-phosphohydrolase in the central nervous system. J. Neurochem. 14 (1967) 1167-1174
28. Lee J.H., Kim H.S., Lee S.J., and Kim K.T. Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death. J. Cell Sci. 120 (2007) 2259-2271
29. Lee M.S., Kwon Y.T., Li M., Peng J., Friedlander R.M., and Tsai L.H. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405 (2000) 360-364
30. Leite M.C., Brolese G., de Almeida L.M., Pinero C.C., Gottfried C., and Goncalves C.A. Ammonia-induced alteration in S100B secretion in astrocytes is not reverted by creatine addition. Brain Res. Bull. 70 (2006) 179-185
31. Li B.S., Veeranna, Gu J., Grant P., and Pant H.C. Activation of mitogen-activated protein kinases (Erk1 and Erk2) cascade results in phosphorylation of NF-M tail domains in transfected NIH 3T3 cells. Eur. J. Biochem. 262 (1999) 211-217
32. Maccioni R.B., Otth C., Concha I.I., and Munoz J.P. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology. Eur. J. Biochem. 268 (2001) 1518-1527
33. McCollum A.T., Nasr P., and Estus S. Calpain activates caspase-3 during UV-induced neuronal death but only calpain is necessary for death. J. Neurochem. 82 (2002) 1208-1220
34. Meijer L., Borgne A., Mulner O., Chong J.P., Blow J.J., Inagaki N., Inagaki M., Delcros J.G., and Moulinoux J.P. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243 (1997) 527-536
35. Moran C.M., Donnelly M., Ortiz D., Pant H.C., Mandelkow E.M., and Shea T.B. Cdk5 inhibits anterograde axonal transport of neurofilaments but not that of tau by inhibition of mitogen-activated protein kinase activity. Brain Res. Mol. Brain Res. 134 (2005) 338-344
36. Mouatt-Prigent A., Karlsson J.O., Agid Y., and Hirsch E.C. Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?. Neuroscience 73 (1996) 979-987
37. Nikolic M., Dudek H., Kwon Y.T., Ramos Y.F., and Tsai L.H. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 10 (1996) 816-825
38. O'Hare M.J., Kushwaha N., Zhang Y., Aleyasin H., Callaghan S.M., Slack R.S., Albert P.R., Vincent I., and Park D.S. Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death. J. Neurosci. 25 (2005) 8954-8966
39. Olney J.W., Wozniak D.F., Jevtovic-Todorovic V., Farber N.B., Bittigau P., and Ikonomidou C. Drug-induced apoptotic neurodegeneration in the developing brain. Brain Pathol. 12 (2002) 488-498
40. Patel A.J., Hunt A., Gordon R.D., and Balazs R. The activities in different neural cell types of certain enzymes associated with the metabolic compartmentation glutamate. Brain Res. 256 (1982) 3-11
41. Patrick G.N., Zukerberg L., Nikolic M., de La Monte S., Dikkes P., and Tsai L.H. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402 (1999) 615-622
42. Pishak M.R., and Phillips A.T. A modified radioisotopic assay for measuring glutamine synthetase activity in tissue extracts. Anal. Biochem. 94 (1979) 82-88
43. Rajgopal Y., and Vemuri M.C. Calpain activation and alpha-spectrin cleavage in rat brain by ethanol. Neurosci. Lett. 321 (2002) 187-191
44. Ratnakumari L., Qureshi I.A., and Butterworth R.F. Evidence for cholinergic neuronal loss in brain in congenital ornithine transcarbamylase deficiency. Neurosci. Lett. 178 (1994) 63-65
45. Raynaud F., and Marcilhac A. Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease. FEBS J. 273 (2006) 3437-3443
46. Rose C., Kresse W., and Kettenmann H. Acute insult of ammonia leads to calcium-dependent glutamate release from cultured astrocytes, an effect of pH. J. Biol. Chem. 280 (2005) 20937-20944
47. Roth K.A., and D'Sa C. Apoptosis and brain development. Ment. Retard. Dev. Disabil. Res. Rev. 7 (2001) 261-266
48. Rupinder S.K., Gurpreet A.K., and Manjeet S. Cell suicide and caspases. Vascul. Pharmacol. 46 (2007) 383-393
49. Saito T., Konno T., Hosokawa T., Asada A., Ishiguro K., and Hisanaga S. p25/cyclin-dependent kinase 5 promotes the progression of cell death in nucleus of endoplasmic reticulum-stressed neurons. J. Neurochem. 102 (2007) 133-140
50. Schrier B.K., and Shuster L. A simplified radiochemical assay for choline acetyltransferase. J. Neurochem. 14 (1967) 977-985
51. Sharma P., Veeranna, Sharma M., Amin N.D., Sihag R.K., Grant P., Ahn N., Kulkarni A.B., and Pant H.C. Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J. Biol. Chem. 277 (2002) 528-534
52. Shea T.B., Yabe J.T., Ortiz D., Pimenta A., Loomis P., Goldman R.D., Amin N., and Pant H.C. Cdk5 regulates axonal transport and phosphorylation of neurofilaments in cultured neurons. J. Cell Sci. 117 (2004) 933-941
53. Vandenabeele P., Vanden Berghe T., and Festjens N. Caspase inhibitors promote alternative cell death pathways. Sci. STKE 2006 (2006) pe44
54. Veeranna, Amin N.D., Ahn N.G., Jaffe H., Winters C.A., Grant P., and Pant H.C. Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M. J. Neurosci. 18 (1998) 4008-4021
55. Wang Y., White M.G., Akay C., Chodroff R.A., Robinson J., Lindl K.A., Dichter M.A., Qian Y., Mao Z., Kolson D.L., and Jordan-Sciutto K.L. Activation of cyclin-dependent kinase 5 by calpains contributes to human immunodeficiency virus-induced neurotoxicity. J. Neurochem. 103 (2007) 439-455
56. Widmer R., Kaiser B., Engels M., Jung T., and Grune T. Hyperammonemia causes protein oxidation and enhanced proteasomal activity in response to mitochondria-mediated oxidative stress in rat primary astrocytes. Arch. Biochem. Biophys. 464 (2007) 1-11
57. Wilson S.H., Schrier B.K., Farber J.L., Thompson E.J., Rosenberg R.N., Blume A.J., and Nirenberg M.W. Markers for gene expression in cultured cells from the nervous system. J. Biol. Chem. 247 (1972) 3159-3169
58. Wingo W.J., and Waparam J. Decarboxylation of l-glutamic acid by brain. J. Biol. Chem. 187 (1950) 267-271
59. C receptor agonist suppressed ammonia-induced apoptosis in cultured rat hippocampal neurons by restoring phosphorylated BAD level. J. Neurochem. 87 (2003) 791-800
60. Yang L., Omori K., Suzukawa J., and Inagaki C. Calcineurin-mediated BAD Ser155 dephosphorylation in ammonia-induced apoptosis of cultured rat hippocampal neurons. Neurosci. Lett. 357 (2004) 73-75
61. Zheng Y.L., Kesavapany S., Gravell M., Hamilton R.S., Schubert M., Amin N., Albers W., Grant P., and Pant H.C. A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. EMBO J. 24 (2005) 209-220
62. Zurich M.G., Honegger P., Schilter B., Costa L.G., and Monnet-Tschudi F. Involvement of glial cells in the neurotoxicity of parathion and chlorpyrifos. Toxicol. Appl. Pharmacol. 201 (2004) 97-104